X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (25) 25
humans (22) 22
infectious diseases (21) 21
male (21) 21
adult (18) 18
female (18) 18
hiv (13) 13
hiv infections - drug therapy (13) 13
middle aged (13) 13
hiv infections - virology (11) 11
antiretroviral therapy (10) 10
immunology (10) 10
virology (10) 10
viral load (9) 9
microbiology (8) 8
aids (7) 7
cd4 lymphocyte count (7) 7
hiv infection (7) 7
hiv infections - immunology (7) 7
antiviral agents (6) 6
cohort studies (6) 6
immune activation (6) 6
persistence (6) 6
prevalence (6) 6
active antiretroviral therapy (5) 5
aids/hiv (5) 5
hiv-1 (5) 5
hiv-1 - physiology (5) 5
human immunodeficiency virus--hiv (5) 5
pharmacology & pharmacy (5) 5
raltegravir potassium (5) 5
research (5) 5
risk factors (5) 5
treatment outcome (5) 5
analysis (4) 4
anti-hiv agents - therapeutic use (4) 4
cd4-positive t-lymphocytes - immunology (4) 4
cd8-positive t-lymphocytes - immunology (4) 4
clinical trials (4) 4
cohort (4) 4
genotype (4) 4
hiv infections - complications (4) 4
hiv-1 - drug effects (4) 4
human immunodeficiency virus (4) 4
papillomaviridae - isolation & purification (4) 4
pilot projects (4) 4
reservoir (4) 4
spain - epidemiology (4) 4
t cells (4) 4
therapy (4) 4
viremia (4) 4
virus diseases (4) 4
anti-hiv agents - administration & dosage (3) 3
cancer (3) 3
cd4 antigen (3) 3
comparative analysis (3) 3
cyclohexanes - therapeutic use (3) 3
drug administration schedule (3) 3
efavirenz (3) 3
health aspects (3) 3
hiv infections - epidemiology (3) 3
hiv patients (3) 3
hiv-1 - immunology (3) 3
hiv-1 - isolation & purification (3) 3
homosexuality, male (3) 3
hpv (3) 3
human papillomavirus (3) 3
in-vivo (3) 3
individuals (3) 3
infections (3) 3
low-level viremia (3) 3
management (3) 3
maraviroc (3) 3
medicine (3) 3
microbial translocation (3) 3
mortality (3) 3
papillomaviridae - classification (3) 3
papillomavirus infections - epidemiology (3) 3
papillomavirus infections - virology (3) 3
population (3) 3
prospective studies (3) 3
pyrrolidinones - therapeutic use (3) 3
raltegravir (3) 3
raltegravir intensification (3) 3
replication (3) 3
science (3) 3
triazoles - therapeutic use (3) 3
women (3) 3
young adult (3) 3
acquired immune deficiency syndrome--aids (2) 2
age factors (2) 2
aged (2) 2
aged, 80 and over (2) 2
anal cancer (2) 2
animals (2) 2
anti-hiv agents - pharmacology (2) 2
anti-retroviral agents - therapeutic use (2) 2
antiretroviral agents (2) 2
antiretroviral drugs (2) 2
antiretroviral therapy, highly active (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JOURNAL OF VIROLOGY, ISSN 0022-538X, 05/2018, Volume 92, Issue 9
Maraviroc is a CCR5 antagonist used in the treatment of HIV-1 infection. We and others have suggested that maraviroc could reactivate latent HIV-1. To test the... 
HIV-1 | maraviroc | HISTONE DEACETYLASE INHIBITOR | HIV infected | PROTEIN | latency | TRANSCRIPTION | INTENSIFICATION | AP-1 | VORINOSTAT | NF-kappa B | VIROLOGY | VIRUS-REPLICATION | IN-VIVO | GENE-EXPRESSION | persistence | LRA | reservoir | C-JUN
Journal Article
HIV CLINICAL TRIALS, ISSN 1528-4336, 01/2013, Volume 14, Issue 1, pp. 10 - 16
Background: Raltegravir (RAL) constitutes the first available integrase strand transfer inhibitor (INSTI) available in clinical practice. Three independent... 
INFECTIOUS DISEASES | ANTIRETROVIRAL ACTIVITY | VIRUS | EFFICACY | subtype B | SAFETY | ELVITEGRAVIR | COMBINATION THERAPY | SUSCEPTIBILITY | raltegravir | non-B variants | mutations | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | OPTIMIZED BACKGROUND THERAPY
Journal Article
Journal of the International AIDS Society, ISSN 1758-2652, 10/2012, Volume 15, Issue Suppl 3, p. n/a
Journal Article
HIV Medicine, ISSN 1464-2662, 10/2014, Volume 15, Issue 9, pp. 547 - 556
Journal Article
Journal Article
AIDS, ISSN 0269-9370, 09/2012, Volume 26, Issue 15, pp. 1885 - 1894
Objectives: The stability of the reservoir of latently infected memory CD4(+) T-cells may be associated with continuous replenishment from residual HIV-1, not... 
residual replication | bacterial translocation | HIV reservoir | treatment intensification | gut-homing markers | immune activation | INFECTIOUS DISEASES | ASSAY | DECAY | INTEGRASE | COMBINATION THERAPY | ANTIRETROVIRAL THERAPY | IMMUNOLOGY | VIREMIA | IMPACT | REPLICATION | VIROLOGY | INHIBITOR | TREATMENT-NAIVE PATIENTS | Anti-HIV Agents - pharmacology | Prospective Studies | Humans | Middle Aged | Male | Virus Latency - drug effects | Anti-HIV Agents - administration & dosage | CD4-Positive T-Lymphocytes - immunology | Pyrrolidinones - administration & dosage | Acquired Immunodeficiency Syndrome - immunology | Lymphocyte Activation - immunology | HIV-1 - physiology | Pyrrolidinones - pharmacology | Adult | Female | Raltegravir Potassium | Drug Administration Schedule | HIV-1 - drug effects | Treatment Outcome | CD4 Lymphocyte Count | Viremia - drug therapy | Acquired Immunodeficiency Syndrome - drug therapy | Acquired Immunodeficiency Syndrome - physiopathology | Pilot Projects | Viremia - virology | Lymphocyte Activation - drug effects | Immunologic Memory | Immunocompromised Host | CD8-Positive T-Lymphocytes - immunology | RNA, Viral - drug effects | Viral Load - drug effects | Translocation | Immunological memory | Memory cells | Homing receptors | CD8 antigen | Viremia | antiretroviral therapy | Clinical trials | Latent infection | Adjuvants | Lymphocytes T | CD4 antigen | Lipopolysaccharides | Infection | Cell activation | Digestive tract
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 4/2013, Volume 207, Issue 8, pp. 1235 - 1241
We estimated the effect of sexual behavior, age, and immunodeficiency on the number of high-risk human papillomavirus (HR-HPV) types in the anal canal among... 
T lymphocytes | Statistical median | HIV/AIDS | Human sexual behavior | Human papillomavirus 16 | HIV | Large intestine | Men | AIDS | Infections | Physiological immunosuppression | MSMS | sexual behavior | anal cancer | HR-HPV | POPULATION | INFECTIOUS DISEASES | SQUAMOUS INTRAEPITHELIAL LESIONS | PERSISTENCE | HPV INFECTION | MICROBIOLOGY | IMMUNOLOGY | CANCER | NEOPLASIA | ACTIVE ANTIRETROVIRAL THERAPY | COHORT | HIGH PREVALENCE | Prevalence | Age Factors | Human papillomavirus 16 - classification | HIV Infections - epidemiology | Humans | Middle Aged | DNA, Viral - analysis | Male | Genotyping Techniques | Anal Canal - virology | Papillomaviridae - genetics | Viral Load | Human papillomavirus 16 - isolation & purification | Adult | Papillomavirus Infections - virology | Latin America - epidemiology | Sexual Behavior | Human papillomavirus 16 - pathogenicity | HIV Infections - virology | Papillomavirus Infections - epidemiology | Risk Factors | Genotype | CD4 Lymphocyte Count | Coinfection - epidemiology | HIV - pathogenicity | Papillomaviridae - isolation & purification | Coinfection - virology | Papillomaviridae - pathogenicity | Spain - epidemiology | Papillomaviridae - classification | Poisson Distribution | Sexual Partners | DNA, Viral - genetics | Human papillomavirus 16 - genetics | Demographic aspects | Age factors in disease | Anus | Abnormalities | Sex | Anorectal disorders | Research | HIV infection | Health aspects | Risk factors
Journal Article
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, ISSN 0213-005X, 03/2018, Volume 36, Issue 3, pp. 157 - 164
Introduction: The objective of this study is to estimate the economic impact associated with the optimisation of triple antiretroviral treatment (ART) in... 
TRIPLE TREATMENT | HIV-1 | INFECTIOUS DISEASES | MONOTHERAPY | Antiretroviral Therapy | Optimisation | NON-INFERIORITY TRIAL | MICROBIOLOGY | Budget impact | OPEN-LABEL | Health Expenditures | Cost | MAINTENANCE | RITONAVIR PLUS LAMIVUDINE | Human immunodeficiency virus | INHIBITOR | DUAL TREATMENT
Journal Article
HIV MEDICINE, ISSN 1464-2662, 01/2015, Volume 16, Issue 1, pp. 15 - 23
ObjectivesIn view of the fact that mucosal damage associated with HIV-1 infection leads to microbial translocation despite successful antiretroviral treatment,... 
INFECTIOUS DISEASES | gut-homing 7 receptor | ANTIRETROVIRAL THERAPY | RESTORATION | HUMAN-IMMUNODEFICIENCY-VIRUS | RALTEGRAVIR INTENSIFICATION | microbial translocation | HIV | SOLUBLE CD14 | PLASMA-LEVELS | LYMPHOID-TISSUE | MARAVIROC INTENSIFICATION | IMMUNE ACTIVATION | HIV-1 INFECTION
Journal Article
HIV Medicine, ISSN 1464-2662, 01/2015, Volume 16, Issue 1, p. 15
In view of the fact that mucosal damage associated with HIV-1 infection leads to microbial translocation despite successful antiretroviral treatment, we... 
Antiviral agents | T cells | HIV (Viruses) | HIV infection | Protein binding
Journal Article
JOURNAL OF VIROLOGY, ISSN 0022-538X, 06/2018, Volume 92, Issue 11
In this study, we have characterized quasispecies dynamics and the evolution of viral tropism in naive HIV-1-infected patients treated with a short course of... 
HIV-1 | POPULATION | maraviroc | MONOTHERAPY | R5 tropism | tropism | CXCR4 | RECEPTOR | AIDS | CCR5 ANTAGONIST | INDIVIDUALS | CORECEPTOR USE | VIROLOGY | DM/X4 tropism | CCR5 antagonists | TREATMENT-EXPERIENCED PATIENTS | CCR5 | PROGRESSION
Journal Article
The open virology journal, ISSN 1874-3579, 2012, Volume 6, Issue 1, pp. 144 - 150
A large number of assays designed for genotyping human papillomaviruses (HPV) have been developed in the last years. They perform within a wide range of... 
Automation | genotyping | Human Papillomavirus
Journal Article
Journal of Infection, ISSN 0163-4453, 2012, Volume 66, Issue 1, pp. 57 - 66
Journal Article